Marc advises pharmaceutical, medical device, and other high-tech companies on the full spectrum of contentious and non-contentious intellectual property matters, including patent, trademark, and unfair competition disputes, as well as complex licensing and regulatory arrangements. He also supports life sciences clients in significant regulatory projects and disputes. His practice spans both German and cross-border matters, with substantial experience across Europe, the United States, the Middle East, and Asia.
Marc has served as lead counsel in more than 1,000 intellectual property proceedings, with particular depth in preliminary injunction matters. His experience covers the full lifecycle of IP matters, from early-stage risk assessment and portfolio strategy to contested litigation and resolution. He is known for guiding clients through high-stakes disputes that demand both strategic judgment and deep technical understanding of intellectual property law.
Marc is a recognized thought leader on UPC-related developments, having led key seminars and specialist workshops on the court's impact on European patent litigation.
Recognitions
Selected to the IAM Patent 1000, which identifies the top patent practitioners throughout the world, 2025-2026
Best Lawyers®, 2023–2026: Intellectual Property Law; Information Technology Law; Pharmaceuticals Law; Biotechnology Law and Life Sciences Practice; Healthcare Law
Word Trademark Review‘s WTR 1000, 2026
Credentials
Education
- Fachanwalt für gewerblichen Rechtsschutz , 2007, Certified Expert Lawyer for Intellectual Property
- Court of Appeal, Stuttgart, 1995, Zweites Staatsexamen
- University of Freiburg, 1992, First State Exam
- University of Konstanz, 1989
Professional admissions & qualifications
- Germany
- Unified Patent Court
Professional affiliations
- GRUR – German Association for Intellectual Property and Copyright (Deutsche Vereinigung für gewerblichen Rechtsschutz und Urheberrecht)
- Munich Bar Association